Navigation Links
Neurocrine Biosciences to Present at the A.G. Edward's Annual Emerging Growth Conference
Date:9/17/2007

Live audio webcast Wednesday, September 19, 2007

SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Neurocrine Biosciences will present at the A.G. Edwards Annual Emerging Growth Conference. The live presentation takes place Wednesday, September 19, 2007 at 1:30 p.m. Eastern Time (ET) /10:30 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical Company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, endometriosis, pain, irritable bowel syndrome, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , NOVATO, Calif., Nov. 30 /PRNewswire-Firs...MRN ) announced today that the Food and Drug Admin...n for 3,4-diaminopyridine (3,4-DAP), amifampridine...t Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has p...E.U. Also, in October 2009, the Committee for Med...
(Date:11/30/2009)..., , SHANGHAI, Nov. 30 /PRNewswire-...pharmaceutical, biotechnology, and medical-device ...operations in China and the United States,announc...ology Fast 50 China,2009 list for the fifth consec...wing companies in China,s technology, media, and t...
(Date:11/28/2009)... The Vanuatu National Advi...ts Second National Communication (SNC) Project in ...ices and CLIMsystems Ltd. of New Zealand have gene...e results that will form the background for the co...Framework Convention on Climate Change (UNFCCC). ...
(Date:11/26/2009)..., , WEST LAFAYETTE, Ind. - A new generation of ul...ips using tiny structures called semiconducting na...y by researchers at IBM, Purdue University and the...researchers have learned how to create nanowires w... defined at the atomic level, which is a critical ...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
...Soliris(R) Sales Reflect Strong 2007 Launch; Posit... U.S. and International Markets, Fourth Quarter...ulizumab) net product sales were $33.9 million in ... million in Q3 2007., * Q4 GAAP net loss was $12....AP net loss of $20.1 million, or $0.55 per share, ...
...Three-Year Extension for Integrated Drug Discovery...s for the Treatment of Huntington Disease, HAMBUR...ornia, February,14 Evotec AG (Frankfurt Stock Exc...Inc., a not-for-profit organization,pursuing a bio...Disease,(HD), has extended its collaboration with ...
..., Nanotechnology researchers are developing the p...able to generate electricity to power small electr... others whose physical motion could be harnessed a... 14 issue of the journal Nature details how pairs ...s can generate electrical current using the piezoe...
Other Biology Technology:Alexion Reports Fourth Quarter and Full Year 2007 Results 2Alexion Reports Fourth Quarter and Full Year 2007 Results 3Alexion Reports Fourth Quarter and Full Year 2007 Results 4Alexion Reports Fourth Quarter and Full Year 2007 Results 5Alexion Reports Fourth Quarter and Full Year 2007 Results 6Alexion Reports Fourth Quarter and Full Year 2007 Results 7Alexion Reports Fourth Quarter and Full Year 2007 Results 8Alexion Reports Fourth Quarter and Full Year 2007 Results 9Alexion Reports Fourth Quarter and Full Year 2007 Results 10Alexion Reports Fourth Quarter and Full Year 2007 Results 11Alexion Reports Fourth Quarter and Full Year 2007 Results 12Alexion Reports Fourth Quarter and Full Year 2007 Results 13Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million 2Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million 3Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million 4Fiber-based nanotechnology in clothing could harvest energy from physical movement 2Fiber-based nanotechnology in clothing could harvest energy from physical movement 3Fiber-based nanotechnology in clothing could harvest energy from physical movement 4
(Date:11/30/2009)...of lower early bird registration rates and registe...s of 2010 at http://www.iofwco-ecceo10.org/ , ...International Osteoporosis Foundation (IOF) and th...ts of Osteoporosis and Osteoarthritis (ESCEO). Mor...e expected to attend. The exciting scientific prog...
(Date:11/30/2009)...lorless and odorless radioactive gas that is produ...a product of uranium decay and is found in trace a...roundwater as well as building materials, plants, ...ion is expressed as the amount of radiation that w... a liter of air; thus the units are picocuries per...
(Date:11/26/2009).... (November 26, 2009) Whitehead researchers have ...ells to pinpoint specific genes and proteins used ... . , In most human cell cultures genes are prese...d one from the mother. Gene inactivation by mutati...is inactivated, the second copy usually remains ac...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Knockouts in human cells point to pathogenic targets 2U S Court of Appeals Upholds AstraZeneca AWP Settlement 6446 1U S Court of Appeals Upholds AstraZeneca AWP Settlement 6446 2U S Court of Appeals Upholds AstraZeneca AWP Settlement 6446 3Spanish biotechnology should focus on food and plant sectors to be more competitive 14936 1Spanish biotechnology should focus on food and plant sectors to be more competitive 14936 2H1N1 Pandemic May Have Peaked in October in U S According to Quest Diagnostics 61864 1H1N1 Pandemic May Have Peaked in October in U S According to Quest Diagnostics 61864 2H1N1 Pandemic May Have Peaked in October in U S According to Quest Diagnostics 61864 3
... capable of metacognition—that is, they can posses...ility, which can also be thought of as the capacit...es, was previously only recognized in humans and o...n Foote and Jonathon Crystal of the University of ...iology, published by Cell Press, on March 8th. , A...
...n ovarian cancer may present a new target for diag...ccording to researchers at the University of Illin...f Pharmacy found that interfering with the product...d invasiveness of tumor cells in test-tube experim...human ovarian tumors overexpressed polypyrimidine ...
...om the lungs of transplant patients demonstrates f...de in adult organs and are not derived from bone m...ls may be able to help with the rejection of donat... , The study by University of Michigan Health Syst... number of lung transplant patients who experience...
Other Biology News:Metacognition: Faced with a test, rats can check their knowledge first 2RNA splicing factor implicated in ovarian tumor cell growth 2Type of stem cell found to reside in transplanted lungs 2Type of stem cell found to reside in transplanted lungs 3
Anti-Yersinia pestis Monoclonal Antibody, Unconjugated from ViroStat Inc.
Rabbit Anti-Olfactory Receptor LS189744 Polyclonal Antibody, Unconjugated from Abcam
Anti-Varicella-zoster Virus, Nucleocapsid Protein Monoclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Zeralenone Monoclonal Antibody, Unconjugated, Clone 11C9 from Abcam
Biology Products: